Oculis Labs Inc

Oculis Labs Inc. develops biopharmaceutical therapies for eye diseases. The Company conducts research in neuro-ophthalmology and ophthalmology, and manages clinical trials for new drug candidates. Oculis Labs Inc serves patients with conditions such as diabetic macular edema, dry eye disease, and acute optic neuritis in Switzerland, Iceland, and the United States.